Cases 21 - 30 of 238
CELGENE CORPORATION v. QILU PHARMACEUTICAL CO. LTD.
as 2:2022cv03753
Plaintiff:
CELGENE CORPORATION
Defendant:
QILU PHARMACEUTICAL CO. LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. ONCOGEN PHARMA (MALAYSIA) SDN. BHD.
as 2:2022cv02952
Plaintiff:
CELGENE CORPORATION
Defendant:
ONCOGEN PHARMA (MALAYSIA) SDN. BHD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
HEALTHCOR OFFSHORE MASTER FUND, L.P. et al v. CELGENE CORPORATION et al
as 2:2022cv02404
Plaintiff:
HEALTHCOR OFFSHORE MASTER FUND, L.P., HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P., BLACKSTONE ALTERNATIVE MULTI-STRATEGY SUB FUND IV L.L.C. and others
Defendant:
CELGENE CORPORATION, SCOTT A. SMITH, TERRIE CURRAN and others
CELGENE CORPORATION v. MSN LABORATORIES PRIVATE LIMITED et al
as 2:2022cv01993
Plaintiff:
CELGENE CORPORATION
Defendant:
MSN LABORATORIES PRIVATE LIMITED and MSN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MSP RECOVERY CLAIMS, SERIES LLC et al v. CELGENE CORPORATION et al
as 2:2021cv20451
Plaintiff:
MSP RECOVERY CLAIMS, SERIES LLC, MSPA CLAIMS 1, LLC, MAO-MSO RECOVERY II, LLC, SERIES PMPI, A SEGREGATED SERIES OF MAO-MSO RECOVERY II, LLC and others
Defendant:
CELGENE CORPORATION and BRISTOL-MYERS SQUIBB COMPANY
Cause Of Action: 15 U.S.C. § 2
Celgene Corporation et al v. Accord Healthcare Inc.
as 1:2021cv01795
Plaintiff:
Celgene Corporation and Celgene International Sarl
Defendant:
Accord Healthcare Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HIKMA PHARMACEUTICALS USA, INC.
as 2:2021cv20459
Plaintiff:
CELGENE CORPORATION
Defendant:
HIKMA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. ALEMBIC PHARMACEUTICALS LIMITED et al
as 2:2021cv20099
Plaintiff:
CELGENE CORPORATION
Defendant:
ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC GLOBAL HOLDING SA and ALEMBIC PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271
Nimbus Therapeutics, LLC et al v. Celgene Corporation et al
as 1:2021cv06850
Plaintiff:
Nimbus Therapeutics, LLC and Nimbus Lakshmi, Inc.
Defendant:
Celgene Corporation and Bristol-Myers Squibb Company
Cause Of Action: 28 U.S.C. § 2201 dj Declaratory Judgment
Celgene Corporation v. Hetero Labs Limited
as 21-2335
Plaintiff / Appellant:
CELGENE CORPORATION
Defendant / Appellee:
HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED and others
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
